Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

807.65
-2.6600-0.33%
Post-market: 807.650.00000.00%16:05 EDT
Volume:563.43K
Turnover:453.82M
Market Cap:83.15B
PE:19.97
High:808.63
Open:803.83
Low:796.73
Close:810.31
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.92
T/O Rate:0.57%
Dividend:3.64
Dividend Rate:0.45%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.62
PE(LYR):19.47

Loading ...

Sanofi, Regeneron Could Extend Dupixent Patent

Dow Jones
·
Yesterday

BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $920 From $800, Keeps Outperform Rating

MT Newswires Live
·
Yesterday

Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800

THOMSON REUTERS
·
Yesterday

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Yesterday

CytomX Highlights Varseta-M EpCAM Topo-1 ADC Data in Late-Line Metastatic Colorectal Cancer Presentation

Reuters
·
Yesterday

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Reuters
·
Sep 04

Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 04

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 03

Movement Alert|Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Sep 03

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.01% in Regular Trading, RBC Says Company Weighing Expanded Sanofi Partnership

Market Focus
·
Sep 02

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.
·
Sep 01

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27